Leading Team in Medical Dermatology and Aesthetics
Jere Fellmann, PhD
Head of Development Operations
Jere Fellmann, PhD served as Vice President, Clinical Operations at Kythera Biopharmaceuticals, Inc. from June, 2012 until it was acquired by Allergan in October, 2015. Dr. Fellmann is the co-founder of Ocellus Inc., a materials science and multidisciplinary consulting company, and has served as its Director since it’s founding in 1996.
Dr. Fellmann was Vice President, Clinical Operations and Project Management from October 2004 to September 2007 at Acologix, Inc., a biopharmaceutical company. Dr. Fellmann has also held leadership positions at various other life sciences companies, including Eunoe, Inc., Symyx Technologies, Elan Pharmaceuticals, Inc. (Elan) and Neurex Corporation (Neurex). While at Neurex, Dr. Fellmann was instrumental in gaining approval for CORLOPAM® a first in class antihypertensive and while at Elan was the World Wide Development Leader for PRIALT® a first in class medication for the treatment of neuropathic pain.
Dr. Fellmann has authored or co-authored numerous publications and patents. Dr. Fellmann received a BS in Chemistry from the University of California, Berkeley and a PhD in Inorganic/Organometallic Chemistry from the Massachusetts Institute of Technology.